硫化通过降低矩阵金属蛋白酶-9的调节来改善心脏衰老
Kaichuan He1, Huaxing Zhang2, Bo Tan3
1Department of Physiology, Hebei Medical University, 050017, Hebei, China.
Cardiovascular drugs and therapy
|June 17, 2024
概括
补充硫化 (H2S) 通过减少矩阵金属蛋白酶-9 (MMP-9) 和改善心脏功能来对抗与年龄有关的心脏衰退. 这项研究表明,H2S在衰老期间保持心脏结构和功能.
科学领域:
- 心血管科学 心血管科学
- 衰老研究研究 衰老研究
- 生物化学 生物化学
背景情况:
- 衰老是心血管疾病的主要危险因素,其特点是心脏中的矩阵金属蛋白酶-9 (MMP-9) 的增加和硫化 (H2S) 的减少.
- 与年龄相关的心脏功能障碍包括扩张功能受损,纤维化和结构变化.
研究的目的:
- 调查外源H2S补充能否抵消与年龄相关的心脏衰退.
- 为了确定H2S对心脏H2S水平的影响,MMP-9表达,以及老化中的心脏形态和功能.
主要方法:
- 对与人类年龄相关的血H2S和MMP-9水平的分析.
- 给老年小鼠注射硫化物 (NaHS) 并评估心脏功能,结构,纤维化和分子标志物 (MMP-9,CSE).
- 使用小干扰RNA进行体外研究,以阐明MMP-9和cystathionine gamma-lyase (CSE) 之间的关系.
主要成果:
- 在人体中,血H2S水平下降,而MMP-9水平随着年龄的增长而增加.
- 老年小鼠表现出心脏H2S降低,腹功能受损,心脏纤维化增加.
- 在老年小鼠中补充H2S改善了心脏功能,结构,并减少了纤维化和MMP-9表达.
结论:
- 硫化 (H2S) 在衰老的心脏中起着保护作用.
- 在衰老过程中,H2S维持心脏结构和功能,部分是通过抑制MMP-9表达来实现.
相关概念视频
Role of Matrix Metalloproteases in Degradation of ECM
2.4K
Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
2.4K
Aging
41
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
41
Mitochondria
12.1K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
12.1K
The Effect of Aging on Tissues
2.1K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
2.1K
Bone Disorders
3.5K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.5K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
420
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
420


